Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy
- 1 February 2007
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 29 (2), 253-260
- https://doi.org/10.1016/j.clinthera.2007.02.008
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trialAmerican Heart Journal, 2006
- Statin Safety: A Systematic ReviewThe American Journal of Cardiology, 2006
- Statin Safety and Drug Interactions: Clinical ImplicationsThe American Journal of Cardiology, 2006
- Statin-related adverse events: A meta-analysisClinical Therapeutics, 2006
- Can Low-Density Lipoprotein Be Too Low? The Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein With Intensive Statin TherapyJournal of the American College of Cardiology, 2005
- Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary DiseaseNew England Journal of Medicine, 2005
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary SyndromesNew England Journal of Medicine, 2004
- Statin-Associated MyopathyJAMA, 2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001